Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ArcticZymes Technologies Director's Dealing 2017

Aug 30, 2017

3538_dirs_2017-08-30_d9a54c38-e5ed-4b59-b3b0-52d4975669fd.html

Director's Dealing

Open in viewer

Opens in your device viewer

Mandatory notification of trade

Mandatory notification of trade

(Tromsø 30. August 2017) Jan Raa, Board member and primary insider of

Biotec Pharmacon has today sold 20.000 shares in Biotec Pharmacon at NOK 6,50

per share. After this transaction holds Mr. Raa 311.105 shares in Biotec

Pharmacon

This information is subject to the disclosure requirements pursuant to section 5

-12 of the Norwegian Securities Trading Act.